Centrix is all set to launch contract research (CRO) service to facilitate the international CRO companies to expand their operations in India and South East Asia. Indian contract research business is predicted to grow exponentially over the next five years.

India with its large and diverse population and a broad spectrum of disease relevant to the global pharma and biotech markets, offers excellent potential for conducting large and complex clinical trials at low cost.

Centrix with its customer base, broad presence in web based medical communication can be a platform to International CROs for collaborations.

Centrix has team of experts who can processes and manage the transition from nonclinical to Phase I development swiftly and successfully, which provide a preliminary evaluation of pharmacokinetics and pharmacodynamic end points, drug safety and tolerance etc.

The company has the capability of providing insight and expertise of scientists, clinicians, and regulators, with competencies that cover almost all aspects of the drug development process. Centrix can under take traditional clinical trial design and is capable of providing high -quality data on time and within budget.

Centrix can present the resulting information in most suitable formats for regulatory submissions. The company ensures clean data from the very start of the clinical trials and bio equivalence studies, which ensures efficiency of results during final analysis and on ward submissions. This authentic and clean data provide information, which is necessary for making critical and efficient decisions during the clinical trials. At centrix the data mangers and biostatisticians are integral part of the investigating teams and thus provide a platform for all necessary innovations for accurate and relevant investigations.

Post-marketing Services

Centrix is capable to undertake all the post-marketing activities of the pharmaceutical companies as open label phase IV trials, Maintenance of safety database, Bioequivalance studies for generic drugs and post marketing research etc.